Vandetanib
Ended Awarded Last action
- Contract number
- VA26014F3883
- Awardee
-
Astrazeneca LIMITED Partnership UEI FBWCB39K5929
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $7,335
Award facts
- Contract value 100% obligated
- $7,335.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, DE 19803, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$88,019 | |
| Original award | $95,354 |
Quick answers
Who was awarded contract VA26014F3883?
VA26014F3883 was awarded to Astrazeneca LIMITED Partnership by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2013.
How much is contract VA26014F3883 worth?
The government has obligated $7,335 on VA26014F3883.
Is contract VA26014F3883 an order under another contract?
Yes. VA26014F3883 is a delivery order under V797P2211D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26014F3883 competed?
The extent of competition for VA26014F3883 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award